New Product Marketing Authorizations in the pharmaceutical industry refer to the official approvals granted by regulatory authorities, such as the FDA, EMA, or other national agencies, allowing a company to market and sell a new drug or medicinal product. This process involves the submission of comprehensive data on the product's quality, safety, and efficacy gathered through preclinical and clinical studies. Securing marketing authorization is a critical milestone in a product’s lifecycle, ensuring it meets all regulatory standards for patient use. It also provides legal assurance for commercialization, enabling companies to introduce innovative therapies to global markets while ensuring......See More